Evidence map›Paper›PMID 32393187›Full record

ArticleBMC nephrology2020

Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.

Bingqing Lyu, Weili Wang, Xin-Ying Ji, Joseph K Ritter, Ningjun Li

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Sphingolipid signaling in kidney diseases.American journal of physiology. Renal physiology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Nephrotoxicity in cancer treatment: An update.Advances in cancer research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Bingqing LyuSchool of Basic Medical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, Guizhou, China.
Weili WangDepartment of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, P.O. Box 980613, Richmond, VA, 23298, USA.
Xin-Ying JiHenan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, 475004, Henan, China.
Joseph K RitterDepartment of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, P.O. Box 980613, Richmond, VA, 23298, USA.
Ningjun LiDepartment of Pharmacology & Toxicology, Virginia Commonwealth University School of Medicine, P.O. Box 980613, Richmond, VA, 23298, USA. nli@vcu.edu.
Virginia Commonwealth University · USGuizhou University · CNHenan University · CN

Funding

Renal sphingosine-1-phosphate receptor 1 in salt-sensitive hypertensionR01HL145163 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, NINGJUN · 2019 to 2022
$1.6M
Renomedullary metabolism of anandamide and blood pressure regulationR01DK102539 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, PINLAN, RITTER, JOSEPH K. · 2016 to 2019
$1.4M
Molecular mechanism of hypertension-induced renal injury: the role of HIF-1alphaR01DK107991 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, NINGJUN · 2017 to 2019
$698k
Renomedullary metabolism of anandamide and blood pressure regulationR56DK102539 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, PINLAN, RITTER, JOSEPH K. · 2014 to 2014
$92k
NHLBI NIH HHS HL145163NHLBI NIH HHS R01 HL145163NIDDK NIH HHS DK102539NIDDK NIH HHS DK107991NIDDK NIH HHS R01 DK102539NIDDK NIH HHS R01 DK107991NIDDK NIH HHS R56 DK102539
6 · The paper itself

Abstract

backgroundSphingosine-1-phosphate (S1P) is a bioactive metabolite of sphingolipids and produced by sphingosine kinases (SphK1 and SphK2). SphK1/S1P pathway is implicated in the progression of chronic kidney disease. However, the role of SphK1/S1P pathway in renal injury in hypertension has not been reported. This study tested the hypothesis that SphK1/S1P pathway mediates the kidney damage in DOCA-salt hypertensive mice.

methodsMale wild type (WT) C57BL6 and SphK1 knockout (KO) mice were subjected to unilateral nephrectomy, subcutaneous implant containing 50 mg of deoxycorticosterone acetate (DOCA) and 1% NaCl drinking water for 7 weeks. At the end of experiments, blood pressure data, 24 h urine and kidney samples were collected. Renal mRNA levels of SphK1 were measured by real-time RT-PCR. Markers for fibrogenesis and immune cell infiltration in kidneys were detected using Western blot and immunohistochemistray analysis, respectively. The glomerular morphological changes were examined in kidney tissue slides stained with Periodic-Acid Schiff. Four groups were studied: wild type control (WT-C), WT-DOCA, KO-C and KO-DOCA.

resultsThe renal SphK1 mRNA expression was significantly upregulated in WT-DOCA mice, whereas this upregulation of renal SphK1 mRNA was blocked in KO-DOCA mice. There was no difference in DOCA-salt-induced hypertension between WT and KO mice. The urinary albumin was increased in both DOCA-salt groups. However, the albuminuria was significantly lower in KO-DOCA than in WT-DOCA group. There were increases in glomerulosclerosis indices in both DOCA-salt groups, whereas the increases were also significantly lower in KO-DOCA than in WT-DOCA mice. Renal protein levels of α-smooth muscle actin were upregulated in both DOCA-salt groups, but the increase was significant lower in KO-DOCA than in WT-DOCA group. The increased staining areas of collagen detected by Sirius Red-staining in kidney tissue sections were also attenuated in KO-DOCA compared with WT-DOCA mice. In contrast, the increased infiltration of CD43+ (a T cell marker) or CD68+ (a macrophage marker) cells in DOCA-salt kidneys showed no significant difference between WT-DOCA and KO-DOCA mice.

conclusionsSphK1/S1P signaling pathway mediates kidney damage in DOCA-salt hypertensive mice independent of blood pressure and immune modulation.

Indexed as

ActinsAlbuminuriaAnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticBlotting, WesternCD68 MoleculeCollagenDesoxycorticosterone AcetateDisease Models, AnimalFibrosisHypertensionImmunohistochemistryKidneyLeukosialinLysophospholipidsActinsalpha-smooth muscle actin, mouseAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 MoleculeCD68 protein, mouseCollagenDesoxycorticosterone AcetateLeukosialinLysophospholipidsMineralocorticoidsPhosphotransferases (Alcohol Group Acceptor)RNA, MessengerSodium Chloride, DietarySphingosinesphingosine 1-phosphateSphingosine KinaseSphk1 protein, mouseSpn protein, mouseCollagen, hypertensionSphingosine-1-phosphateα-Smooth muscle actin

Identifiers

PMID32393187
PMCPMC7216348
OpenAlexW3028060910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.